Next report date
Report period
Q1 2024
EPS estimate
−0.38USD
Revenue estimate
—
−39.26 MUSD
22.96 M
Om Reviva Pharmaceuticals Holdings, Inc.
Sektor
Bransch
VD
Laxminarayan Bhat
Webbplats
Huvudkvarter
Cupertino
Employees (FY)
15
Grundat
2020
FIGI
BBG00LJZ8FW8
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
